UB Paderborn / Katalog / Suche / in CDI

Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore

PloS one, 2014-12, Vol.9 (12), p.e114310-e114310

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival

Journal of gastrointestinal surgery, 2014, Vol.18 (1), p.16-25

2014

Link zum Volltext

Verfügbarkeit prüfen

Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?

Journal of gastrointestinal surgery, 2015-01, Vol.19 (1), p.80-87

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas

Journal of gastrointestinal surgery, 2016-12, Vol.20 (12), p.1966-1974

2016

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer

Journal of gastrointestinal surgery, 2023-02, Vol.27 (2), p.319-327

2023

Link zum Volltext

Verfügbarkeit prüfen

Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

Journal of gastrointestinal surgery, 2014-02, Vol.18 (2), p.269-278

2014

Link zum Volltext

Verfügbarkeit prüfen

Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy

Journal of gastrointestinal surgery, 2023-10, Vol.27 (10), p.2135-2144

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria

Journal of gastrointestinal surgery, 2023-12, Vol.27 (12), p.2806-2814

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk-Stratified Pancreatectomy Clinical Pathway Implementation and Delayed Gastric Emptying

Journal of gastrointestinal surgery, 2021-09, Vol.25 (9), p.2221-2230

2021

Link zum Volltext

Verfügbarkeit prüfen

Home-based exercise during preoperative therapy for pancreatic cancer

Langenbeck's archives of surgery, 2017-12, Vol.402 (8), p.1175-1185

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors

Journal of gastrointestinal surgery, 2017, Vol.21 (1), p.155-163

2017

Link zum Volltext

Verfügbarkeit prüfen

Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis

Journal of gastrointestinal surgery, 2017-04, Vol.21 (4), p.636-646

2017

Link zum Volltext

Verfügbarkeit prüfen

Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection

Journal of gastrointestinal surgery, 2012-09, Vol.16 (9), p.1696-1704

2012

Link zum Volltext

Verfügbarkeit prüfen

Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality

Journal of gastrointestinal surgery, 2016-12, Vol.20 (12), p.1975-1985

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer

Journal of gastrointestinal surgery, 2012, Vol.16 (1), p.68-79

2012

Link zum Volltext

Verfügbarkeit prüfen

Physical activity and exercise during preoperative pancreatic cancer treatment

Supportive care in cancer, 2019-06, Vol.27 (6), p.2275-2284

2019

Link zum Volltext

Verfügbarkeit prüfen

After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant Readmissions

Journal of gastrointestinal surgery, 2016-01, Vol.20 (1), p.77-84

2016

Link zum Volltext

Verfügbarkeit prüfen

Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors

Journal of gastrointestinal surgery, 2015-11, Vol.19 (11), p.2011-2018

2015

Link zum Volltext

Verfügbarkeit prüfen

Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification

Journal of gastrointestinal surgery, 2014, Vol.18 (1), p.146-156

2014

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy for Resectable and Borderline Resectable Pancreas Cancer: When and Why?

Journal of gastrointestinal surgery, 2021-03, Vol.25 (3), p.843-848

2021

Link zum Volltext

Verfügbarkeit prüfen

A High Positive Lymph Node Ratio is Associated with Distant Recurrence after Surgical Resection of Ampullary Carcinoma

Journal of gastrointestinal surgery, 2012-11, Vol.16 (11), p.2056-2063

2012

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Borderline Resectable Pancreatic Cancer

Current treatment options in oncology, 2013-09, Vol.14 (3), p.293-310

2013

Link zum Volltext

Verfügbarkeit prüfen

Robotic Duodenojejunostomy Bypass for Metastatic Pancreatic Body Cancer

Journal of gastrointestinal surgery, 2022-05, Vol.26 (5), p.1115-1116

2022

Link zum Volltext

Verfügbarkeit prüfen

Defining and Treating Borderline Resectable Pancreatic Cancer

Current treatment options in oncology, 2020-07, Vol.21 (9), p.71, Article 71

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore

Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?

Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas

Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer

Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy

Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria

Risk-Stratified Pancreatectomy Clinical Pathway Implementation and Delayed Gastric Emptying

Home-based exercise during preoperative therapy for pancreatic cancer

Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors

Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis

Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection

Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality

Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer

Physical activity and exercise during preoperative pancreatic cancer treatment

After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant Readmissions

Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors

Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification

Radiotherapy for Resectable and Borderline Resectable Pancreas Cancer: When and Why?

A High Positive Lymph Node Ratio is Associated with Distant Recurrence after Surgical Resection of Ampullary Carcinoma

Treatment of Borderline Resectable Pancreatic Cancer

Robotic Duodenojejunostomy Bypass for Metastatic Pancreatic Body Cancer

Defining and Treating Borderline Resectable Pancreatic Cancer

Aktive Filter

Suchergebnisse filtern